What does Malin Corporation invest in?
Malin Corporation invests most often at Venture and Series B (60% of the rounds on record), in sectors such as Biotechnology and Life Science.

Last cheque observed Apr 2019. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.
QuietGrowth equity
5 rounds on record
Mostly Venture and Series B: 60% of its rounds
Sole investor in 1 rounds, median $50M
Every round we can evidence, newest first5 appearances
1 round
4 rounds
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
Malin Corporation invests most often at Venture and Series B (60% of the rounds on record), in sectors such as Biotechnology and Life Science.
5 investments on record, 0 of them in the last 12 months. The most recent was in Apr 2019.
Its most recent investments on record: Poseida Therapeutics (Series C, Apr 2019).
The median round it joins is $142M.
Rarely, if at all: none of its 5 investments on record names it as the lead.
Most of the companies it backs are in the United States (60%) and the United Kingdom (40%).
No investments in the last 12 months; the latest was in Apr 2019.
Malin Corporation is a growth equity firm.
Find the investors who back rounds like yours, and keep every conversation on one fundraising board.
Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it